Wegovy Cost: Pills and Pens (semaglutide)

Wegovy price by strength

Cheapest ways to get Wegovy 2.4 mg

The cheapest ways we found to get brand Wegovy 2.4 mg (prices checked Nov 5, 2026). The lowest 90-day cost is shaded green.

Costs abroad and at U.S. pharmacies are for one order closest to 90 days, shipping included, from the price table above. Programs set their own rules, so check the terms before you count on one.

How much does Wegovy cost without insurance?

Without insurance, Wegovy costs $1,445.38 for a 30-day supply at the U.S. list price, or about $4,336.14 for 90 days.

Self-pay pens: $349 per 28-day box for 0.25 mg to 2.4 mg, or $399 for Wegovy HD 7.2 mg. New patients pay $199 for their first two fills of 0.25 mg or 0.5 mg (NovoCare).

Self-pay pill: $149 (1.5 mg), $199 (4 mg) or $299 (9 mg or 25 mg) for 30 tablets (NovoCare).

Wegovy cost with Medicare

In 2026, a Medicare drug plan (Part D) can charge a deductible of up to $615, and once you've spent $2,100 out of pocket on covered drugs, you pay nothing more for covered drugs that year ($2,400 in 2027) (Medicare.gov). What you pay for Wegovy depends on your plan's drug list and your coverage phase. Starting January 1, 2027, Medicare will pay a negotiated price of $274 for a 30-day supply of semaglutide (Ozempic, Rybelsus and Wegovy) (CMS, checked Oct 30, 2026). That's what Medicare will pay, not your copay. If your income is limited, Extra Help lowers drug costs: in 2026 you pay no more than $5.10 for a generic and $12.65 for a brand-name drug, with income under $23,940 ($32,460 for a married couple) and resources under $18,090 ($36,100 for a couple) (CMS). The free Medicare Prescription Payment Plan spreads costs into monthly payments, but it doesn't lower the total. Since July 1, 2026, the temporary Medicare GLP-1 Bridge lets eligible Part D members get Wegovy pens or pills for $50 a month; that $50 doesn't count toward the out-of-pocket limit (Medicare.gov).

Wegovy cost with insurance

With private or employer insurance, what you pay for Wegovy depends on your plan's drug list, deductible and copay. As little as $25 a month with the Wegovy Savings Offer if your plan covers Wegovy, up to $100 off per month. If your plan doesn't cover it, you can pay the self-pay price (NovoCare).

Medicaid: Coverage depends on your state's Medicaid program. You can also choose Novo Nordisk's self-pay price if you don't bill Medicaid for it (NovoCare).

Wegovy patient assistance program

Not that we could find. Novo Nordisk Patient Assistance Program is Novo Nordisk's free-medicine program, but Wegovy wasn't on its list of medicines when we checked on 2026-10-29 (official page). If you have Medicare and a limited income, Medicare Extra Help can lower what you pay.

Wegovy FAQ

Savings programs from the maker

eDrugSearch does not offer its own Wegovy coupons. These are the real savings programs, run by Novo Nordisk and by Medicare:

• Wegovy Savings Offer: for people with commercial insurance that covers Wegovy. Eligible patients may pay as little as $25, with savings of up to $100 per 1-month fill ($200 for 2 months, $300 for 3 months). Not for anyone enrolled in Medicare, Medicaid, VA, TRICARE or another federal or state program with drug coverage. Questions: 1-888-793-1218. (Wegovy Savings Offer terms)
• Wegovy self-pay offer: Novo Nordisk's cash price for anyone with a valid prescription: $349 a month for pens up to 2.4 mg, $399 for Wegovy HD 7.2 mg, $149 to $299 for the pill, and $199 for a new patient's first two fills of 0.25 mg or 0.5 mg (prescriptions written by December 31, 2026). It can't be combined with other offers, and you can't bill insurance for it. With Medicare or Medicaid, you can pay this cash price, but it won't count toward your plan (or Medicare's yearly out-of-pocket cap, $2,100 in 2026). With private insurance, ask your plan whether a cash purchase counts toward your deductible. (NovoCare)
• Medicare GLP-1 Bridge: a temporary Medicare program that started July 1, 2026. Eligible adults with Part D pay $50 for a one-month supply of Wegovy pens or tablets. The $50 doesn't count toward your Part D deductible or out-of-pocket limit and can't be added to the Medicare Prescription Payment Plan. You must meet body mass index (BMI) and health criteria, and your doctor may need to send a prior authorization. People with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease can't use the Bridge, but their Part D plan may cover a GLP-1. (Medicare.gov)
• Medicare Extra Help: if you have Medicare and limited income, Extra Help lowers what you pay for drugs your Part D plan covers. It can't lower the $50 GLP-1 Bridge copay. (Social Security)

Compare Wegovy with similar drugs

Other GLP-1 medicines people often compare with Wegovy, including Ozempic and Rybelsus, which also contain semaglutide. Prices are for each drug's lowest-priced strength.

Lowest 90-day price including shipping, from licensed pharmacies shipping to the U.S., any strength. Only your doctor can decide whether another drug is right for you.

What is Wegovy used for?

Wegovy (semaglutide) is a GLP-1 receptor agonist. According to its FDA label (FDA), it is used along with a reduced-calorie diet and more physical activity to:

• Lower the risk of heart attack, stroke and death from heart disease in adults with heart disease who also have obesity or overweight (pens and tablets).
• Help adults with obesity, or with overweight and at least one weight-related health problem, lose weight and keep it off (pens and tablets).
• Help children 12 and older with obesity lose weight and keep it off (pens only).
• Treat MASH, a liver disease, with moderate to advanced liver scarring in adults who don't have cirrhosis (pens only). This use has accelerated approval, which may depend on further studies.

Wegovy comes as once-weekly pens (0.25 mg, 0.5 mg, 1 mg, 1.7 mg and 2.4 mg, plus Wegovy HD 7.2 mg) and once-daily tablets (1.5 mg, 4 mg, 9 mg and 25 mg). The pens are stored in the refrigerator. Wegovy has a boxed warning about thyroid tumors seen in studies in rodents. Its label says it isn't recommended with other semaglutide or GLP-1 medicines. Your prescriber decides which medicine is right for you.